My
work in the lab focuses on the
role of SOX2 in the developing and adult brain.
The embryonic and adult central nervous systems (CNS) harbor
heterogeneous populations of proliferating neural progenitor cells
which are
capable of generating both neurons and glia in
vivo and in vitro. However, the cellular and molecular
mechanisms which regulate the cell-fate decisions of these distinct
progenitor
populations are unclear. Moreover, the ability to identify neural
progenitor
populations in vivo is hindered by a
lack of defined molecular markers capable of specifically recognizing
these
cells, highlighting the need for additional tools for the continued
analysis of
neural progenitors in vivo.

We have generated a
SOX2EGFP mouse line which allows for the prospective
identification
of SOX2-positive neural progenitor cells in the developing and adult
CNS in vivo (Fig. 1). I have demonstrated that distinct
populations,
specifically radial glial cells and intermediate progenitor cells, can
be prospectively
isolated from the dorsal telencephalon of the brain based upon their
intracellular concentrations of SOX2 (Fig 2 and 3). In
addition, I am currently investigating
the function of SOX2 in the proper maintenance of radial glial cells in
the
dorsal telencephalon and have shown that loss of SOX2 in radial glial
cells
results in a decrease in the number of proliferating radial glia and
intermediate progenitors, as well as a reduction in their self-renewal
capacity.
